What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

DIC: Disseminated Intravascular Coagulation Explained

Name: DIC: Disseminated Intravascular Coagulation Explained
Creator: Dr. Zubair Khalid

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Disseminated intravascular coagulation (DIC) is an acquired, life-threatening condition defined by systemic activation of coagulation, impaired fibrinolysis, and endothelial injury, producing widespread microthrombi that consume platelets and clotting factors and lead to paradoxical bleeding [1]. It is never a primary disease. DIC is always the downstream consequence of another disorder, most often sepsis, severe trauma, pancreatitis, heatstroke, hemangiosarcoma, immune-mediated hemolytic anemia, or obstetric catastrophe [2][3].

DIC matters because it sits at the intersection of every major emergency in veterinary medicine. A dog with hemangiosarcoma that suddenly oozes from every venipuncture site, a cat in septic shock with petechiae on the gingiva, a horse with African horse sickness that bleeds from the nostrils, all may share the same final common pathway [2][4]. Recognizing DIC changes how a clinician interprets a falling platelet count, a prolonged clotting time, and a patient who is simultaneously clotting and bleeding.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

What DIC Actually Is

The 2025 International Society on Thrombosis and Haemostasis (ISTH) definition frames DIC as an acquired, life-threatening condition involving systemic coagulation activation, impaired fibrinolysis, and endothelial injury [1]. The same framework classifies DIC into three phases: pre-DIC, early-phase DIC (also called subclinical or compensated DIC), and overt DIC [1]. Early-phase DIC is characterized by laboratory abnormalities that precede clinical symptoms, while overt DIC represents advanced disease with clear coagulopathy and organ failure [1].

The unifying theme across all phases is excessive thrombin generation, or a failure to localize thrombin production to the site of injury [3]. Thrombin converts fibrinogen to fibrin, activates platelets, and feeds back to amplify its own production. When this process escapes local control, fibrin strands deposit throughout the microvasculature, and the same platelets and factors needed for hemostasis are consumed in the process.

The Paradox of Clotting and Bleeding

Students often struggle with the idea that a patient can be clotting and bleeding at the same time. The resolution lies in scale. Microthrombi form in small vessels throughout the body, causing organ ischemia and dysfunction. Simultaneously, the consumption of platelets and clotting factors, combined with activation of the fibrinolytic system, leaves the patient unable to form a stable clot at sites of actual injury [2]. A dog with DIC may have fibrin thrombi occluding glomerular capillaries while bleeding from the nasal mucosa.

Pathophysiology Step by Step

Step 1: Tissue Factor Exposure

The coagulation cascade begins when tissue factor (TF), a transmembrane protein normally sequestered from circulating blood, becomes exposed to factor VII. In DIC, TF exposure is widespread. Endothelial damage, monocyte activation, and neutrophil activation all upregulate TF expression [5]. In African horse sickness, for example, pathologic activation of hemostasis is proposed to result from tissue factor expression due to vascular endothelial damage or dysfunction [4]. The TF-VIIa complex activates factor X and factor IX, initiating the common pathway and generating thrombin.

Step 2: Cytokine-Driven Amplification

Inflammatory cytokines, particularly interleukin-6 and tumor necrosis factor-alpha, amplify the process. They drive TF expression on monocytes and endothelial cells, downregulate the natural anticoagulant pathways (antithrombin, protein C, and tissue factor pathway inhibitor), and promote platelet activation [3][5]. The complement system also contributes. In a study of 49 adult sepsis patients, complement activation through the alternative pathway was associated with thrombocytopenia and increased sepsis severity, and patients with both DIC and complement activation had a 60-day all-cause mortality of 66 percent compared with 14 percent in the DIC-alone group and 0 percent in the complement-activation-alone group [6].

Step 3: Microthrombus Formation and Consumption

As thrombin generation becomes systemic, fibrin deposits in small vessels. Platelets are consumed, and clotting factors, especially fibrinogen, factor V, and factor VIII, are depleted. This consumption coagulopathy explains the laboratory hallmarks of DIC: thrombocytopenia, prolonged prothrombin time (PT), prolonged activated partial thromboplastin time (aPTT), and low fibrinogen [2][3].

Step 4: Impaired Fibrinolysis

The body attempts to dissolve the fibrin clots through fibrinolysis, but this system is profoundly impaired in DIC. Initially, fibrinolytic insufficiency was attributed to elevated plasma levels of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor [5]. More recently, research has shown that DIC-associated fibrinolytic insufficiency during septic shock involves plasminogen degradation driven by neutrophil elastase carried by neutrophil extracellular traps circulating in patients' plasma [5]. The failure to resolve the hypercoagulable state and restore hemostatic balance is a key determinant of poor outcomes [5].

Step 5: Endothelial Glycocalyx Degradation

The endothelial glycocalyx (eGCX) is a gel-like layer of proteoglycans and glycosaminoglycans that coats the luminal surface of endothelial cells and regulates vascular permeability, leukocyte adhesion, and coagulation. In obstetric DIC, eGCX degradation, indicated by elevated syndecan-1, heparan sulfate, and hyaluronic acid levels, has been associated with disease severity and may reflect early endothelial dysfunction [7]. Crystalloid overload, ischemia-reperfusion injury, and inflammatory cytokines promote glycocalyx shedding, which exacerbates vascular permeability and consumption coagulopathy [7].

Step 6: The Phenotypic Spectrum

DIC is not a single phenotype. In trauma, it manifests as a dynamic, heterogeneous spectrum: an initial hyperfibrinolytic phenotype followed by a thrombotic phenotype characterized by microvascular thrombosis and organ dysfunction [8]. In sepsis, the dominant picture is often a prothrombotic state with suppressed fibrinolysis [5]. In some cancers, particularly prostatic adenocarcinoma in humans and nasal adenocarcinoma in dogs, a hyperfibrinolytic phenotype can dominate, causing severe bleeding [9]. This variability means that two patients with DIC may have opposite clinical presentations.

The following diagram traces the main pathway from trigger to clinical outcome.

flowchart TD
    A[Underlying trigger] --> B[Tissue factor exposure]
    B --> C[Cytokine amplification]
    C --> D[Systemic thrombin generation]
    D --> E[Microthrombus formation]
    E --> F[Platelet and factor consumption]
    E --> G[Organ ischemia]
    F --> H[Paradoxical bleeding]
    G --> I[Multiple organ failure]
    C --> J[Impaired fibrinolysis]
    J --> E
    C --> K[Endothelial glycocalyx damage]
    K --> E

Veterinary Triggers of DIC

DIC is always secondary to an underlying condition [3]. The trigger determines the phenotype, the tempo, and often the treatment priority.

Sepsis

Sepsis is the most common trigger in small animal practice. The prothrombotic profile arises from upregulated tissue factor expression by endothelial cells, monocytes, and neutrophils, combined with insufficient regulation by endogenous anticoagulant pathways [5]. Between 30 and 40 percent of septic shock patients develop DIC, which is associated with a 60 percent increase in mortality [5]. In a study of critically ill patients admitted to the ICU, microclots defined as amyloid-fibrinogen aggregates were detected in 42.3 percent of patients on admission and were associated with a primary diagnosis of sepsis [10]. Patients with either a high number or larger-sized microclots had a higher likelihood of developing DIC (odds ratio 51.4) and an increased probability of 28-day mortality [10].

Pancreatitis

Severe pancreatitis releases proteolytic enzymes and damage-associated molecular patterns that activate coagulation and inflammation. A case report described a dog with diffuse microscopic pancreatic adenocarcinoma, normal imaging, and grossly normal pancreas on exploratory laparotomy, complicated by sterile peritonitis and DIC [11]. This case highlights that pancreatic pathology can trigger DIC even without a visible mass or gross metastasis [11].

Heatstroke

Heatstroke causes direct thermal injury to endothelial cells, widespread cytokine release, and disseminated coagulation activation. The combination of hyperthermia, dehydration, and endothelial damage creates a perfect storm for DIC.

Hemangiosarcoma

Hemangiosarcoma, particularly of the spleen and right atrium, is a classic veterinary trigger for DIC. The tumor disrupts normal endothelium, exposes blood to subendothelial tissue factor, and sheds procoagulant microparticles. Dogs with hemangiosarcoma may present with acute collapse from tumor rupture and concurrent DIC, making surgical and anesthetic management extremely challenging.

Immune-Mediated Hemolytic Anemia (IMHA)

IMHA triggers DIC through multiple mechanisms. Intravascular hemolysis releases hemoglobin and red cell membrane fragments that activate coagulation. The intense inflammatory response and endothelial activation further drive TF expression. Dogs with IMHA often have thrombocytopenia that is partly immune-mediated and partly consumption-related.

Severe Trauma

Traumatic DIC is a catastrophic complication in severely injured patients, profoundly impacting morbidity and mortality [8]. Recent advances frame traumatic DIC as a failure of immunothrombosis, driven by damage-associated molecular patterns, neutrophil extracellular traps, and catastrophic endotheliopathy [8]. Shock-induced endotheliopathy, antithrombin leakage, and traumatic brain injury-specific triggers all contribute [8]. The management of traumatic DIC is phased: early viscoelastic testing-guided damage control resuscitation and tranexamic acid for hemorrhage, followed by late-phase viscoelastic testing prophylaxis and targeted anticoagulant use to manage thrombosis [8].

Heartworm Caval Syndrome

Caval syndrome is a serious complication of chronic heartworm disease in dogs and cats, characterized by retrograde migration of adult heartworms into the right ventricle, right atrium, and venae cavae [12]. Red blood cells are traumatized and hemolyzed as they flow through the mass of worms, and DIC may develop [12]. The prognosis is generally guarded to poor [12].

Snake Envenomation

Australian Eastern brown snake envenomation causes venom-induced consumptive coagulopathy (VICC) in dogs and cats due to toxin-induced consumption of clotting factors [13]. In a retrospective study of 240 dogs and 98 cats, 92 percent of dogs and cats were diagnosed with VICC on presentation, and median time to normalization of coagulation tests was 24 hours [13]. While VICC is mechanistically distinct from DIC, the consumptive coagulopathy and clinical bleeding can look identical.

Infectious Triggers in Other Species

DIC is not limited to dogs and cats. African horse sickness virus infection in horses results in overt DIC, with clinical signs including submucosal petechiae and prolonged bleeding post venipuncture [4]. In dugongs, a systemic Achromobacter xylosoxidans infection caused septicemia-associated DIC with fibrin thrombi, hemorrhage, and multisystemic lesions [14].

Key Laboratory Findings

No single test confirms DIC. The diagnosis rests on a combination of history, clinical signs, and laboratory abnormalities interpreted together. The 2025 ISTH criteria emphasize that diagnostic criteria should be tailored to the underlying disease, such as sepsis, trauma, or malignancy [1].

Table: Laboratory Parameters in DIC

Parameter	Direction of Change	Mechanism	Notes
Platelet count	Decreased	Consumption in microthrombi	Often the earliest change
PT	Prolonged	Consumption of factors II, V, VII, X	Prolongation of 20 to 30 percent is significant [3]
aPTT	Prolonged	Consumption of factors VIII, IX, XI, XII	May be normal in early DIC
Fibrinogen	Decreased	Consumption exceeding hepatic synthesis	May be normal or elevated in early DIC as an acute phase reactant
D-dimer	Elevated	Fibrin degradation	ISTH 2025 revised thresholds: greater than 3 times upper normal limit equals 2 points, greater than 7 times equals 3 points [1]
FDP	Elevated	Fibrinogen and fibrin degradation	FDP includes both fibrin and fibrinogen breakdown products
Schistocytes	Present	Mechanical shearing of red cells by fibrin strands	Seen on blood smear
Antithrombin	Decreased	Consumption and leakage	Contributes to thrombotic phenotype [8]

Interpreting the Numbers

In a retrospective study of women transferred for primary postpartum hemorrhage, 18 percent were diagnosed with obstetric DIC, and severe maternal outcomes occurred more frequently in the DIC group than in the non-DIC group (55 percent versus 24 percent) [15]. Fibrinogen levels were significantly lower in the severe group (163 mg/dL versus 241 mg/dL), whereas FDP and D-dimer levels showed no significant differences between groups [15]. This finding underscores that fibrinogen is a critical parameter in obstetric DIC, and a declining fibrinogen should raise concern even when D-dimer is not dramatically elevated.

The 2025 ISTH update refined the overt DIC scoring system, including revised D-dimer thresholds [1]. Platelet count, prothrombin time, fibrinogen, and D-dimer are the core components of the scoring system, but the weighting and interpretation depend on the clinical context [1].

Viscoelastic Testing

Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) provide a global assessment of clot formation and lysis. In horses experimentally infected with African horse sickness virus, TEG variables showed increased clot initiation time (R) and decreased alpha-angle, maximum amplitude (MA), and clot strength (G), consistent with a hypocoagulable state [4]. Viscoelastic testing is particularly valuable in trauma because it can distinguish hyperfibrinolytic from thrombotic phenotypes and guide resuscitation [8].

Blood Smear Examination

Schistocytes, fragmented red blood cells, are a hallmark of microangiopathic hemolysis. They form when red cells are sliced by fibrin strands in the microvasculature. Finding schistocytes on a blood smear in a patient with thrombocytopenia and prolonged clotting times strongly supports a diagnosis of DIC.

Clinical Relevance, Limitations and Common Mistakes

DIC Is a Diagnosis of Exclusion

There is no gold-standard test for DIC. The diagnosis requires a compatible underlying condition, appropriate clinical signs, and supportive laboratory findings. Other causes of thrombocytopenia and coagulopathy, such as immune-mediated thrombocytopenia, liver failure, anticoagulant rodenticide toxicity, and congenital factor deficiencies, must be ruled out. The 2025 ISTH framework explicitly states that diagnostic criteria are tailored to the underlying disease [1].

Treat the Cause, Not the Number

The single most important principle in managing DIC is to treat the underlying trigger. A dog with pyometra and DIC needs an emergency ovariohysterectomy. A dog with hemangiosarcoma and DIC needs surgical control of bleeding if possible. A horse with African horse sickness and DIC needs supportive care, as no specific antiviral is available. Transfusion of fresh frozen plasma, packed red blood cells, or platelets may be necessary to support the patient through the crisis, but these are temporizing measures [16][9].

Common Mistakes

Mistake 1: Waiting for bleeding to diagnose DIC. Early-phase DIC is characterized by laboratory abnormalities that precede clinical symptoms [1]. By the time a patient is bleeding from multiple sites, the disorder is often advanced.

Mistake 2: Relying on a single laboratory test. A normal fibrinogen does not exclude DIC, because fibrinogen is an acute phase reactant and may be elevated in early disease even as it is being consumed. A normal platelet count does not exclude DIC if the patient started with a high platelet count.

Mistake 3: Confusing DIC with VICC. Venom-induced consumptive coagulopathy from snake envenomation causes consumption of clotting factors but is not driven by the same cytokine and endothelial mechanisms as DIC [13]. The distinction matters because antivenom, not DIC-directed therapy, is the treatment.

Mistake 4: Assuming all DIC is thrombotic. Trauma-associated DIC begins with a hyperfibrinolytic phenotype before transitioning to a thrombotic phenotype [8]. Treating a hyperfibrinolytic patient with anticoagulants would be catastrophic.

Mistake 5: Forgetting that DIC is always secondary. If the underlying cause is not identified and treated, no amount of blood product support will change the outcome.

Limitations

Individual cases require individualized assessment by a veterinarian. The laboratory findings and clinical signs described here are general patterns, and species differences exist. For example, cats may show different coagulation profiles than dogs, and equine DIC may present with a more hemorrhagic phenotype [4][3].

Quick Review

DIC is an acquired, life-threatening condition involving systemic coagulation activation, impaired fibrinolysis, and endothelial injury [1].
It is always secondary to an underlying trigger such as sepsis, trauma, pancreatitis, heatstroke, hemangiosarcoma, IMHA, or obstetric catastrophe [2][3].
The core mechanism is excessive thrombin generation that escapes local control, leading to microthrombi and consumption of platelets and clotting factors [3].
Key laboratory findings include thrombocytopenia, prolonged PT and aPTT, low fibrinogen, elevated D-dimers or FDPs, and schistocytes on blood smear [2][1].
Fibrinolytic insufficiency in sepsis involves plasminogen degradation by neutrophil elastase carried by neutrophil extracellular traps [5].
DIC is a diagnosis of exclusion, and treatment focuses on the underlying cause [1].
The 2025 ISTH criteria classify DIC into pre-DIC, early-phase DIC, and overt DIC, with criteria tailored to the underlying disease [1].

Frequently Asked Questions

What causes DIC in dogs?

DIC in dogs is caused by an underlying condition that triggers widespread coagulation activation. Common triggers include sepsis, hemangiosarcoma, pancreatitis, immune-mediated hemolytic anemia, heatstroke, severe trauma, and heartworm caval syndrome [2][3][12].

What are the first signs of DIC?

The first signs of DIC are often subtle and related to the underlying disease. Early-phase DIC is characterized by laboratory abnormalities such as a falling platelet count and prolonged clotting times before clinical bleeding appears [1]. As DIC progresses, petechiae, ecchymoses, bleeding from venipuncture sites, and organ dysfunction may develop.

Can DIC be cured?

DIC can resolve if the underlying cause is identified and treated effectively. However, it carries high mortality, particularly in sepsis and trauma [8][5]. Treatment focuses on supporting the patient through the crisis while addressing the trigger.

How is DIC diagnosed?

DIC is diagnosed by combining clinical signs, history, and laboratory findings. Key tests include complete blood count with platelet count, PT, aPTT, fibrinogen, D-dimer or FDP, and blood smear examination for schistocytes [2][1]. Viscoelastic testing may be used in trauma and critical care settings [8].

What is the difference between DIC and VICC?

DIC is driven by systemic coagulation activation, impaired fibrinolysis, and endothelial injury [1]. VICC, or venom-induced consumptive coagulopathy, is caused by snake venom toxins that directly consume clotting factors [13]. Both cause bleeding, but the mechanisms and treatments differ.

Is DIC painful for my pet?

DIC itself is not typically described as painful, but the underlying condition and the organ ischemia caused by microthrombi can cause significant discomfort. Pets with DIC often appear weak, lethargic, and may have difficulty breathing if pulmonary thrombi are present.